Diversified Trust’s Lexicon Pharmaceuticals LXRX Stock Holding History

Diversified Trust’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,695	Closed	-$25K	–	764
2020 Q3	$25K	Hold	17,695	–	–	﹤0.01%	646
2020 Q2	$35K	Buy	+17,695	New	+$34.7K	﹤0.01%	556

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Diversified Trust's LXRX Position: Q4 2020 in Review

Diversified Trust sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2020, closing a stake of 17,695 shares — an estimated $25K sold.

Diversified Trust first reported a position in LXRX in Q2 2020 and held it in 2 quarters. The position peaked at $35K in Q2 2020. 106 funds tracked by Wall St. Rank hold LXRX as of Q4 2020.

Diversified Trust reported no remaining Lexicon Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Diversified Trust sold 17,695 Lexicon Pharmaceuticals shares in Q4 2020, an estimated $25K.
Diversified Trust first reported a position in Lexicon Pharmaceuticals in Q2 2020 and held it in 2 quarters.
Diversified Trust's Lexicon Pharmaceuticals position peaked at $35K in Q2 2020.
106 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2020.

Based on Diversified Trust's 13F filing for Q4 2020, filed 8 Jan 2021.